Aude advises start-ups and large global corporations in the U.S., EU, and Japan. Since joining Alira Health in 2012, Aude has managed over 100 corporate strategy, commercial due diligence, pre-commercial value assessments, and M&A projects in MedTech and Pharma. Previously, Aude was as an M&A analyst at BNP Paribas and a strategy analyst at Novartis Pharma. A registered U.S. investment banker with FINRA Series 79 and 63 certifications, Aude also manages Alira Health Ventures companies.
Key areas of expertise
- Drug Delivery Systems and Medical Contract Manufacturing
- Infection Prevention
- Wound Care
- Digital Health
- AI in Drug Discovery
- Biopharmaceutical Assets and Pre-commercial Value Assessments